Brighter days ahead: the shifting landscape of IBD therapy

Current Opinion in Gastroenterology · Published 2025-10-10 · DOI 10.1097/mog.0000000000001139

Authors being retrieved — see the publisher record. https://doi.org/10.1097/mog.0000000000001139

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• Endobariatrics in the era of glucagon-like peptide-1 receptor agonists: evolving roles, evidence, and integration · Current Opinion in Gastroenterology · 2025 · Same journal
• Emerging insights in gastric cancer pathogenesis · Current Opinion in Gastroenterology · 2026 · Same journal
• Eosinophilic esophagitis – more than eosinophils? · Current Opinion in Gastroenterology · 2026 · Same journal
• Current opinion in gastroenterology · Current Opinion in Gastroenterology · 2026 · Same journal
• Plasma exchange in acute liver failure · Current Opinion in Gastroenterology · 2026 · Same journal
• Gastrointestinal endoscopy: keeping up with the times · Current Opinion in Gastroenterology · 2025 · Same journal
• The use of potassium-competitive acid blockers in the management of foregut disease · Current Opinion in Gastroenterology · 2026 · Same journal
• Laxative logic: when lifestyle is not enough · Current Opinion in Gastroenterology · 2025 · Same journal
• Mechanistic insights into pancreatic duct pressure: from basic physiology to translational implications · Current Opinion in Gastroenterology · 2026 · Same journal
• Implementation science: a primer for hepatology research · Current Opinion in Gastroenterology · 2026 · Same journal